Union Korea Pharm Statistics

Total Valuation

Union Korea Pharm has a market cap or net worth of KRW 19.70 billion. The enterprise value is 51.10 billion.

Market Cap	19.70B
Enterprise Value	51.10B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Union Korea Pharm has 7.23 million shares outstanding. The number of shares has decreased by -2.78% in one year.

Current Share Class	n/a
Shares Outstanding	7.23M
Shares Change (YoY)	-2.78%
Shares Change (QoQ)	-11.29%
Owned by Insiders (%)	37.99%
Owned by Institutions (%)	n/a
Float	3.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.30
PB Ratio	0.69
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.51
EV / Sales	0.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	58.16

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 1.15.

Current Ratio	0.74
Quick Ratio	0.50
Debt / Equity	1.15
Debt / EBITDA	n/a
Debt / FCF	29.08
Interest Coverage	-3.54

Financial Efficiency

Return on equity (ROE) is -62.85% and return on invested capital (ROIC) is -15.31%.

Return on Equity (ROE)	-62.85%
Return on Assets (ROA)	-10.09%
Return on Capital (ROIC)	-15.31%
Revenue Per Employee	327.01M
Profits Per Employee	-104.04M
Employee Count	196
Asset Turnover	0.65
Inventory Turnover	3.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.99% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-42.99%
50-Day Moving Average	2,725.00
200-Day Moving Average	4,559.48
Relative Strength Index (RSI)	32.14
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Union Korea Pharm had revenue of KRW 64.09 billion and -20.39 billion in losses. Loss per share was -2,905.16.

Revenue	64.09B
Gross Profit	25.54B
Operating Income	-15.97B
Pretax Income	-16.64B
Net Income	-20.39B
EBITDA	-12.76B
EBIT	-15.97B
Loss Per Share	-2,905.16

Full Income Statement

Balance Sheet

The company has 4.33 billion in cash and 25.55 billion in debt, giving a net cash position of -21.23 billion or -2,935.99 per share.

Cash & Cash Equivalents	4.33B
Total Debt	25.55B
Net Cash	-21.23B
Net Cash Per Share	-2,935.99
Equity (Book Value)	22.19B
Book Value Per Share	3,924.34
Working Capital	-15.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.70 billion and capital expenditures -1.82 billion, giving a free cash flow of 878.60 million.

Operating Cash Flow	2.70B
Capital Expenditures	-1.82B
Free Cash Flow	878.60M
FCF Per Share	121.53

Full Cash Flow Statement

Margins

Gross margin is 39.85%, with operating and profit margins of -24.91% and -31.81%.

Gross Margin	39.85%
Operating Margin	-24.91%
Pretax Margin	-25.96%
Profit Margin	-31.81%
EBITDA Margin	-19.91%
EBIT Margin	-24.91%
FCF Margin	1.37%

Dividends & Yields

Union Korea Pharm does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.78%
Shareholder Yield	2.78%
Earnings Yield	-106.61%
FCF Yield	4.46%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Union Korea Pharm has an Altman Z-Score of -0.1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.1
Piotroski F-Score	n/a